At today's OPPO INNO DAY 2020, OPPO announced the launch of a companion diagnostic research platform for the Covid-19.
The suite of Covid-19 assisted diagnostic research platforms achieves 99.76% recognition accuracy, according to OPPO.
OPPO said the platform provides a mature deep learning framework for medical researchers and will be donated or made available to healthcare organizations free of charge to create a faster and more effective screening tool to aid in the diagnostic process for normalized epidemic prevention and control.
